Latest Laboratory Certification News

Page 1 of 1

Lumos Diagnostics Hits Halfway Mark in FebriDx CLIA Waiver Study, Eyes $1B US Market

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.

Ada Torres

2 June 2025

Top